Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
PEDIACEL and Prevenar · 1 trial · 5 indications
| Arm | Type | Description |
|---|---|---|
| Group 1 | EXPERIMENTAL | PEDIACEL co-administered with Prevenar |
| Group 2 | ACTIVE_COMPARATOR | Infanrix-IPV+Hib co-administered with Prevenar |
| Name | Type | Description |
|---|---|---|
| PEDIACEL® and Prevenar® | BIOLOGICAL | 0.5 mL each, IM (opposite thigh) |
| Infanrix®-IPV+Hib and Prevenar® | BIOLOGICAL | 0.5 mL each, IM (opposite thigh) |
Inclusion Criteria: * Infants 55 to 75 days old, inclusive on the day of first vaccination * Born at full term of pregnancy (\> 37 weeks) * Informed consent form signed by the parent(s) or the legal guardian * Parents or the legal guardian able to read and write in the local language * Parent(s) or...
PEDIACEL and Prevenar are investigational vaccines studied for the prevention of diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b. They are being developed by Sanofi (SNY) for use in infants and toddlers, with a focus on infectious disease prevention.
Sanofi (SNY) is developing PEDIACEL and Prevenar. These are investigational vaccines studied in a Phase 3 clinical trial for the prevention of multiple infectious diseases, including diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b.
PEDIACEL and Prevenar are in Phase 3 clinical development. They are investigational vaccines and have not been approved for use. A Phase 3 trial has been completed to evaluate their safety and immunogenicity when co-administered in infants and toddlers.
PEDIACEL and Prevenar have one completed Phase 3 clinical trial, NCT00343421, which enrolled 588 participants in France and Poland. The study compared Pediacel to Infanrix-IPV+Hib when both were co-administered with Prevenar in infants and toddlers.
PEDIACEL and Prevenar are vaccines designed to stimulate the immune system to produce antibodies against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b. They are administered to infants and toddlers to help prevent these infectious diseases.